NIM
IMNM icon

NEOS Investment Management’s Immunome IMNM Stock Holding History

NEOS Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-103,585
Closed -$2.23M – 615
2025
Q4 		$2.23M Sell
103,585
-58,601
-36% -$1.03M 0.01% 460
2025
Q3 		$1.9M Buy
162,186
+46,755
+41% +$465K 0.01% 451
2025
Q2 		$1.07M Buy
+115,431
New +$946K 0.01% 466

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

NEOS Investment Management's IMNM Position: Q1 2026 in Review

NEOS Investment Management sold out of Immunome (IMNM) in Q1 2026, closing a stake of 103,585 shares — an estimated $2.23M sold.

NEOS Investment Management first reported a position in IMNM in Q2 2025 and held it in 3 quarters. The position peaked at $2.23M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • NEOS Investment Management reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 103,585 Immunome shares in Q1 2026, an estimated $2.23M.
  • NEOS Investment Management first reported a position in Immunome in Q2 2025 and held it in 3 quarters.
  • NEOS Investment Management's Immunome position peaked at $2.23M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.